Related references
Note: Only part of the references are listed.Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study
Geertje J. Dreyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
Federica Casiraghi et al.
STEM CELLS TRANSLATIONAL MEDICINE (2020)
Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation
Federica Casiraghi et al.
TRANSPLANTATION (2019)
Mesenchymal Stromal Cells for Transplant Tolerance
Manuel Alfredo Podesta et al.
FRONTIERS IN IMMUNOLOGY (2019)
Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis
Jun Zheng et al.
CELL PROLIFERATION (2019)
Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study
Pauline Erpicum et al.
KIDNEY INTERNATIONAL (2019)
Mesenchymal stromal cells for tolerance induction in organ transplantation
Federica Casiraghi et al.
HUMAN IMMUNOLOGY (2018)
Tolerance in clinical liver transplantation
Josh Levitsky et al.
HUMAN IMMUNOLOGY (2018)
Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
Samantha F. H. de Witte et al.
STEM CELLS (2018)
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction
Cesar Ariel Keller et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
Norberto Perico et al.
FRONTIERS IN IMMUNOLOGY (2018)
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
Paul Lohan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mesenchymal stromal cells and autoimmunity
Vito Pistoia et al.
INTERNATIONAL IMMUNOLOGY (2017)
Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study
Olivier Detry et al.
JOURNAL OF HEPATOLOGY (2017)
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Antonio Galleu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study
Daniel C. Chambers et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of proinflammatory monocytes
Fabiany da C. Goncalves et al.
SCIENTIFIC REPORTS (2017)
Natural Killer Cells and Liver Transplantation: Orchestrators of Rejection or Tolerance?
C. Harmon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye
Jung Hwa Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice
J. Levitsky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
Mehdi Najar et al.
CYTOTHERAPY (2016)
Mesenchymal stromal cells in renal transplantation: opportunities and challenges
Federica Casiraghi et al.
NATURE REVIEWS NEPHROLOGY (2016)
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
Guang-hui Pan et al.
ONCOTARGET (2016)
From immunosuppression to tolerance
David H. Adams et al.
JOURNAL OF HEPATOLOGY (2015)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance
Nina Ketterl et al.
STEM CELL RESEARCH & THERAPY (2015)
Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study
Chetan Mudrabettu et al.
NEPHROLOGY (2015)
High Early Cardiovascular Mortality After Liver Transplantation
Lisa B. VanWagner et al.
LIVER TRANSPLANTATION (2014)
Mesenchymal stem cells: immune evasive, not immune privileged
James A. Ankrum et al.
NATURE BIOTECHNOLOGY (2014)
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Maria Ester Bernardo et al.
CELL STEM CELL (2013)
Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies
Federica Casiraghi et al.
STEM CELL REVIEWS AND REPORTS (2013)
Multipotent Stromal Cells Induce Human Regulatory T Cells Through a Novel Pathway Involving Skewing of Monocytes Toward Anti-inflammatory Macrophages
Sara M. Melief et al.
STEM CELLS (2013)
Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation
Norberto Perico et al.
TRANSPLANT INTERNATIONAL (2013)
Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study
Marlies E. J. Reinders et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation
F. Casiraghi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants A Randomized Controlled Trial
Jianming Tan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation
Felix Bohne et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Multipotent mesenchymal stromal cells and the innate immune system
Katarina Le Blanc et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Solid Organ Allograft Survival Improvement in the United States: The Long-Term Does Not Mirror the Dramatic Short-Term Success
S. A. Lodhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility
Norberto Perico et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs
Alberto Sanchez-Fueyo et al.
GASTROENTEROLOGY (2011)
Prolongation of Composite Tissue Allotransplant Survival by Treatment with Bone Marrow Mesenchymal Stem Cells Is Correlated with T-Cell Regulation in a Swine Hind-Limb Model
Yur-Ren Kuo et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Growth and Differentiation Properties of Mesenchymal Stromal Cell Populations Derived from Whole Human Umbilical Cord
Ingrida Majore et al.
STEM CELL REVIEWS AND REPORTS (2011)
Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study
K. D. S. Watt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Regulatory T-Cell Generation and Kidney Allograft Tolerance Induced by Mesenchymal Stem Cells Associated With Indoleamine 2,3-Dioxygenase Expression
Wei Ge et al.
TRANSPLANTATION (2010)
Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance
W. Ge et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
Kymberly D. S. Watt et al.
GASTROENTEROLOGY (2009)
Mesenchymal Stem Cell and Immunosuppressive Drug Interactions
Fanny Buron et al.
TRANSPLANTATION (2009)
Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells
F. Buron et al.
TRANSPLANTATION PROCEEDINGS (2009)
Bone Marrow-Derived Mesenchymal Stem Cells Inhibit Acute Rejection of Rat Liver Allografts in Association With Regulatory T-Cell Expansion
Y. Wang et al.
TRANSPLANTATION PROCEEDINGS (2009)
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
E. Spaeth et al.
GENE THERAPY (2008)
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells
Federica Casiraghi et al.
JOURNAL OF IMMUNOLOGY (2008)
Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts
C. Capelli et al.
BONE MARROW TRANSPLANTATION (2007)
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury
M. B. Herrera et al.
KIDNEY INTERNATIONAL (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Nonhematopoletic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction
H Kawada et al.
BLOOD (2004)
Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Y Li et al.
NEUROSCIENCE LETTERS (2001)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Share Paper
